Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Western Ontario

$25,000.00

Development of an MR-compatible respiratory control system

EF 2014-15

Résumé
Adjuvant Therapeutics Inc. is a medical device company based in Halifax, focused on providing systems and methods for control of in vivo oxygenation levels in humans. Adjuvant Therapeutics needs to use MRI as a platform in order to provide real-time in-vivo feedback of changes in tissue oxygenation brought about by respiratory control of oxygen and carbon dioxide. In order to achieve this, their existing prototype system must be evaluated and substantially modified in order to operate within the MRI. Dr. Chronik's research group at Western University specializes in the development and testing of MR-compatible medical devices and technology. His group also has full access to industry standard MRI systems at 1.5 T, 3 T and Canada's only 7-T MRI system. It is the ability to conduct comprehensive analysis and testing of medical devices across a wide range of MR platforms that is critical to addressing the challenges for the proposed Adjuvant Medical system.
Programme
Engage Grants Program
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
477345-2014
Name nom
Chronik, Blaine
Department département
Physics and Astronomy
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Development of an MR-compatible respiratory control system
Keyword
NSERC
Application summary
Adjuvant Therapeutics Inc. is a medical device company based in Halifax, focused on providing systems and methods for control of in vivo oxygenation levels in humans. Adjuvant Therapeutics needs to use MRI as a platform in order to provide real-time in-vivo feedback of changes in tissue oxygenation brought about by respiratory control of oxygen and carbon dioxide. In order to achieve this, their existing prototype system must be evaluated and substantially modified in order to operate within the MRI. Dr. Chronik's research group at Western University specializes in the development and testing of MR-compatible medical devices and technology. His group also has full access to industry standard MRI systems at 1.5 T, 3 T and Canada's only 7-T MRI system. It is the ability to conduct comprehensive analysis and testing of medical devices across a wide range of MR platforms that is critical to addressing the challenges for the proposed Adjuvant Medical system.